Colon-targeted oral nanoparticles based on ROS-scavenging hydroxyethyl starch-curcumin conjugates for efficient inflammatory bowel disease therapy

Antioxidant Enzymes Sequestered within Lipid–Polymer Hybrid Nanoparticles for the Local Treatment of Inflammatory Bowel Disease

(2021) Zhicheng Le et al.   ACS Applied Materials & Interfaces

Mutual Two-Way Interactions of Curcumin and Gut Microbiota

(2020) Ryszard Pluta et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Macrophage-based nanotherapeutic strategies in ulcerative colitis

(2020) Jiaxin Zhang et al.   JOURNAL OF CONTROLLED RELEASE

Pathway paradigms revealed from the genetics of inflammatory bowel disease

(2020) Daniel B. Graham et al.   NATURE

Integrated cascade nanozyme catalyzes in vivo ROS scavenging for anti-inflammatory therapy

(2020) Yufeng Liu et al.   Science Advances

Improving Silymarin oral bioavailability using silica-installed redox nanoparticle to suppress inflammatory bowel disease

(2020) Thu-Ha Thi Nguyen et al.   JOURNAL OF CONTROLLED RELEASE

Polyphenols as a versatile component in tissue engineering

(2020) Xize Gao et al.   Acta Biomaterialia

Induction and maintenance treatment of inflammatory bowel disease: A comprehensive review

(2019) Dong Yeon Jeong et al.   AUTOIMMUNITY REVIEWS

Cytokine Networks in the Pathophysiology of Inflammatory Bowel Disease

(2019) Matthias Friedrich et al.   IMMUNITY

Curcumin and Intestinal Inflammatory Diseases: Molecular Mechanisms of Protection

(2019) Kathryn Burge et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Multi-bioresponsive silk fibroin-based nanoparticles with on-demand cytoplasmic drug release capacity for CD44-targeted alleviation of ulcerative colitis

(2019) Shuangquan Gou et al.   BIOMATERIALS

A Comprehensive Review and Update on the Pathogenesis of Inflammatory Bowel Disease

(2019) Qingdong Guan   Journal of Immunology Research

Nano-micelles based on hydroxyethyl starch-curcumin conjugates for improved stability, antioxidant and anticancer activity of curcumin

(2019) Shuting Chen et al.   CARBOHYDRATE POLYMERS

Bioresponsive drug delivery systems in intestinal inflammation: State-of-the-art and future perspectives

(2018) Niranjan G. Kotla et al.   ADVANCED DRUG DELIVERY REVIEWS

Rational Design of Polyphenol-Poloxamer Nanovesicles for Targeting Inflammatory Bowel Disease Therapy

(2018) Xinyu Wang et al.   CHEMISTRY OF MATERIALS

Curcuminoids from Curcuma Longa: New adjuvants for the treatment of crohn's disease and ulcerative colitis?

(2018) Fernando Cunha Neto et al.   CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION

Therapeutic effect of vitamin D 3 -containing nanostructured lipid carriers on inflammatory bowel disease

(2018) Khadijah Zai et al.   JOURNAL OF CONTROLLED RELEASE

Glucocorticoids Inhibit Group 3 Innate Lymphocyte IL-22 Production

(2018) Sudarshan Seshadri et al.   JOURNAL OF IMMUNOLOGY

In situ self-spray coating system that can uniformly disperse a poorly water-soluble H2S donor on the colorectal surface to treat inflammatory bowel diseases

(2018) Wei-Chih Lin et al.   BIOMATERIALS

Site-directed polymer-drug complexes for inflammatory bowel diseases (IBD): Formulation development, characterization, and pharmacological evaluation

(2018) Siddharth S. Kesharwani et al.   JOURNAL OF CONTROLLED RELEASE

pH and Reactive Oxygen Species‐Sequential Responsive Nano‐in‐Micro Composite for Targeted Therapy of Inflammatory Bowel Disease

(2018) Serena Bertoni et al.   ADVANCED FUNCTIONAL MATERIALS

Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies

(2017) Siew C Ng et al.   LANCET

Redox-Sensitive Hydroxyethyl Starch–Doxorubicin Conjugate for Tumor Targeted Drug Delivery

(2016) Hang Hu et al.   ACS Applied Materials & Interfaces

Release-Modulated Antioxidant Activity of a Composite Curcumin-Chitosan Polymer

(2016) Martin G. O’Toole et al.   BIOMACROMOLECULES

Self assembled hyaluronic acid nanoparticles as a potential carrier for targeting the inflamed intestinal mucosa

(2016) Seyed Yaser Vafaei et al.   CARBOHYDRATE POLYMERS

Therapeutic efficacy of quercetin enzyme-responsive nanovesicles for the treatment of experimental colitis in rats

(2015) Ines Castangia et al.   Acta Biomaterialia

Epithelial IL-18 Equilibrium Controls Barrier Function in Colitis

(2015) Roni Nowarski et al.   CELL

Advances in oral nano-delivery systems for colon targeted drug delivery in inflammatory bowel disease: Selective targeting to diseased versus healthy tissue

(2015) Susan Hua et al.   Nanomedicine-Nanotechnology Biology and Medicine

Budesonide loaded nanoparticles with pH-sensitive coating for improved mucosal targeting in mouse models of inflammatory bowel diseases

(2014) H. Ali et al.   JOURNAL OF CONTROLLED RELEASE

Curcumin and Inflammatory Bowel Disease: Potential and Limits of Innovative Treatments

(2014) Liza Vecchi Brumatti et al.   MOLECULES

Natural Products as a Source of Anti-Inflammatory Agents Associated with Inflammatory Bowel Disease

(2013) Trishna Debnath et al.   MOLECULES

Discovery of the curcumin metabolic pathway involving a unique enzyme in an intestinal microorganism

(2011) A. Hassaninasab et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Transferrin as a Luminal Target for Negatively Charged Liposomes in the Inflamed Colonic Mucosa

(2009) Boaz Tirosh et al.   MOLECULAR PHARMACEUTICS

Inflammatory Bowel Disease

(2009) Clara Abraham et al.   NEW ENGLAND JOURNAL OF MEDICINE

Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins

(2008) Ajaikumar B. Kunnumakkara et al.   CANCER LETTERS